OPINION - In my experience, waiting for affordable medications is a matter of life and death. Each day that goes by without ...

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa ...

Sanofi plans to make insulin more affordable and accessible for all patients next year. The company has taken action to fix insulin prices at $35 ...

Sanofi is expanding its U.S. insulin savings program to include all U.S. patients who have a valid prescription, regardless of their insurance status. Sanofi on Friday said the program will offer a 30 ...

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...

Endocrinologists have debunked widespread myths surrounding the use of insulin in the management of diabetes, describing insulin injection as a life-saving treatment essential for controlling blood ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon ...

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

Political commentator Charlie Kirk was shot and killed on Sept. 10 during an event at Utah Valley University. Authorities uncovered a high-powered rifle in the woods and believe it was used against ...

A bill that would cap the price of insulin in California at $35 for a 30-day supply has been approved by the state legislature and is heading to Gov. Gavin Newsom's desk. Senate Bill 40 by State Sen.